Model Number 500DM25 |
Device Problem
Incomplete Coaptation (2507)
|
Patient Problem
Dyspnea (1816)
|
Event Date 11/24/2014 |
Event Type
Injury
|
Event Description
|
Medtronic received information that 25 months post implant (original indication for implant was severe calcific mitral stenosis) of this 25mm open pivot mechanical valve, the patient presented to the hospital with breathlessness.Testing revealed high gradient measurements of 18mm hg and noted one of the leaflets was not moving.Subsequently, the patient required emergency reoperation.The valve was explanted and replaced with a smaller 23mm non-medtronic device.It was reported that the explanted valve will be returned, however has yet been received.No other adverse patient effects were reported.
|
|
Manufacturer Narrative
|
The device has not yet been returned.Without the return of the product, no definitive conclusion can be made regarding the clinical observation.(b)(4).
|
|
Manufacturer Narrative
|
Additional information was received that pannus was noted on the explanted valve.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The device has not yet been returned.Without product return, a conclusive cause of the reported event could not be determined.The reported pannus growth may have hindered movement of the leaflet.This investigation will be reassessed if the device is returned for analysis.
|
|
Manufacturer Narrative
|
Analysis: the explanted valve was received at medtronic received in a semi-cloudy 0.2% glutaraldehyde solution in an explant jar.A visual examination of the device was performed upon receipt.Both leaflets appeared intact with no evidence of damage such as cracks and/or surface anomalies.Both inflow and outflow valve hinge mechanisms appeared intact.The inflow and outflow orifices appear intact with no evidence of damage.Remnants of green and white multifilament sutures remained attached to the existing sewing ring.Pannus overgrowth was observed covering the sewing ring on the outflow and inflow, extending slightly over the orifice on the outflow onto one leaflet.An unknown amount of pannus appears to have been removed on the inflow and outflow during explant; host tissue residue remains on the inflow surface of one leaflet.Conclusion: the pannus observed on the explanted valve would have significantly impaired the leaflet mobility and led to high gradients across the valve.Pannus overgrowth is associated with surgical valve replacement due to patient interaction or the healing response to the surgically implanted valve.Pannus overgrowth is an inherent risk of surgical valve replacement.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|